Shawn David Roman - 27 Jan 2026 Form 4 Insider Report for Apyx Medical Corp (APYX)

Role
Chief Operating Officer
Signature
/s/ Shawn Roman
Issuer symbol
APYX
Transactions as of
27 Jan 2026
Net transactions value
+$21,600
Form type
4
Filing time
29 Jan 2026, 17:21:08 UTC
Previous filing
17 Jan 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Roman Shawn David Chief Operating Officer C/O APYX MEDICAL CORPORATION, 5115 ULMERTON ROAD, CLEARWATER /s/ Shawn Roman 29 Jan 2026 0002048672

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APYX Common Stock Options Exercise $21,600 +12,000 $1.80 12,000 27 Jan 2026 By The Roman Family Revocable Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APYX Stock option (right to buy) Options Exercise $0 -12,000 -100% $0.000000 0 27 Jan 2026 Common Stock 12,000 $1.80 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Held by The Roman Family Revocable Trust of which Reporting Person is both a trustee and beneficiary.
F2 On January 27, 2026, the Reporting Person exercised his stock option awarded on March 16, 2016, to purchase 12,000 shares of the Issuer's common stock at a price of $1.80 per share pursuant to Issuer's 2015 Share Incentive Plan.